Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Antiviral Res. 2012 Dec 29;97(3):280–284. doi: 10.1016/j.antiviral.2012.12.024

Table 1.

Product usage

Products Usage (%)

Menstruation products, such as tampons 64%
Lubrication products such as KY® gels, liquibeads and vitamin-E suppositories 37%
Yeast infection medicines, such as Vagisil® and Monistat® 28%
Douche 8%
Vaginal contraceptive products, such as Nuvaring® 4%
Spermicidal gels and films 2%
Decline to answer 9%